E11.354
Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment
Clinical Classification Guidelines
Medical Intelligence & Overview
Type 2 diabetes mellitus is a chronic condition that affects how your body processes blood sugar (glucose). Over time, high blood sugar levels can lead to various complications, including serious eye problems. The specific code E11.354 describes a severe form of diabetic eye disease where multiple retinal issues have developed. This condition involves proliferative diabetic retinopathy combined with complex retinal detachments, which can seriously threaten vision if not properly managed.
Causes & Symptoms
Clinical Causes: Prolonged elevated blood sugar levels due to diabetes mellitus can damage blood vessels in the retina. Poor control of blood glucose over time increases the risk of developing diabetic retinopathy. High blood pressure often associated with diabetes may contribute to retinal vessel damage. Smoking and high cholesterol levels can further exacerbate blood vessel problems in the eyes. Genetic factors may influence the likelihood of developing severe retinopathy among individuals with diabetes.
Key Symptoms: Gradual loss of vision that can be severe in advanced stages Floaters, flashes of light, or a dark curtain over part of the visual field Blurred or distorted vision Sudden vision loss or a shadow across the field of view, especially in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination, including dilated fundus examination to assess the retina's condition. Imaging tests such as optical coherence tomography (OCT) and fluorescein angiography may be used to identify the extent of blood vessel damage, neovascularization, and retinal detachments. Proper documentation of proliferative changes and retinal tears is crucial for planning appropriate intervention.
Treatment Protocols: Laser photocoagulation to stop abnormal blood vessel growth and reduce risk of bleeding Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents to control neovascularization Surgical procedures such as vitrectomy to remove scar tissue and address retinal detachment Cryotherapy may be used for certain types of retinal tears or detachments Strict control of blood sugar, blood pressure, and cholesterol levels to slow disease progression
Clinical Advice & FAQs
Billing Guidance
Is E11.354 a billable ICD-10 code?
Yes, E11.354 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E11.354?
Clinical documentation must specify the nature of Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment and any associated comorbidities for accurate reporting.
Cite this Clinical Reference